ARWR
$64.19-0.93%
as of close, Oct 2, 2026
☾ AH $64.19 -0.93%
Arrowhead Pharmaceuticals Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.01%
ARWR financial statements
The full income statement, balance sheet, and cash-flow statement for Arrowhead Pharmaceuticals Inc. (ARWR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 124.3M2024-09 124.4M2024-12 126.1M2025-03 138.1M2025-06 138.3M2025-09 135.8M2025-12 140.0M2026-03 140.9M2026-06 141.3M+13.6% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofSep 30 ’25 | as ofSep 30 ’24 | as ofSep 30 ’23 | as ofSep 30 ’22 | as ofSep 30 ’21 | |
| Revenue | 829M+23258.2% | 3.55M-98.5% | 241M-1.0% | 243M+75.9% | 138M+57.2% | |
| 731M+20.9% | 605M+35.6% | 446M+5.7% | 422M+46.8% | 287M+58.6% | ||
| Research & development | 607M+20.0% | 506M+43.2% | 353M+18.8% | 297M+44.1% | 206M+60.1% | |
| Selling, general & administrative | 124M+25.5% | 98.8M+6.7% | 92.5M-25.6% | 124M+53.7% | 81.0M+54.9% | |
| General & administrative | 124M+25.5% | 98.8M+6.7% | 92.5M-25.6% | 124M+53.7% | 81.0M+54.9% | |
| Amortization of intangibles | 1.70M+0.0% | 1.70M+0.0% | 1.70M+0.0% | 1.70M+0.0% | 1.70M+0.0% | |
| Operating income | 98.3M+116.4% | -601M-193.2% | -205M-14.8% | -179M-19.8% | -149M-60.0% | |
| Interest expense | 89.4M+176.2% | 32.4M+76.5% | 18.3M | 0.00 | 0.00 | |
| Other non-operating income | 5.26M+400.9% | -1.75M-213.7% | 1.54M+101.0% | 765K-63.0% | 2.07M+455.1% | |
| Pre-tax income | 51.5M+108.4% | -612M-196.6% | -206M-19.6% | -173M-22.6% | -141M-66.6% | |
| Income tax | 21.4M+874.1% | -2.77M-199.4% | 2.78M-26.4% | 3.79M+189150.0% | 2.00K+0.0% | |
| -1.63M+99.7% | -599M-192.0% | -205M-16.6% | -176M-25.0% | -141M-66.6% | ||
| Net income to non-controlling interest | 31.7M+411.2% | -10.2M-155.0% | -4.00M-828.1% | -431K | 0.00 | |
| -$0.01+99.8% | -$5.00-160.4% | -$1.92-15.0% | -$1.67-22.8% | -$1.36-61.9% | ||
| EPS (basic) | -$0.01+99.8% | -$5.00-160.4% | -$1.92-15.0% | -$1.67-22.8% | -$1.36-61.9% | |
| Weighted-avg shares (basic) | 134M+11.7% | 120M+12.2% | 107M+1.3% | 105M+1.6% | 104M+3.0% | |
| Weighted-avg shares (diluted) | 134M+11.7% | 120M+12.2% | 107M+1.3% | 105M+1.6% | 104M+3.0% | |
| Balance Sheet | as ofSep 30 ’25 | as ofSep 30 ’24 | as ofSep 30 ’23 | as ofSep 30 ’22 | as ofSep 30 ’21 | |
| 951M+36.7% | 695M+67.0% | 416M+2.8% | 405M+5.4% | 385M+19.3% | ||
| Cash & equivalents | 227M+120.6% | 103M-7.4% | 111M+2.7% | 108M-41.4% | 184M+28.5% | |
| Short-term investments | 693M | — | — | 0.00-100.0% | 127M+49.1% | |
| Accounts receivable | 6.82M | 0.00 | 0.00-100.0% | 1.41M-86.3% | 10.3M+1112.2% | |
| Prepaid expenses | 10.9M+14.6% | 9.54M+8.2% | 8.81M+20.9% | 7.29M+67.1% | 4.36M+2.6% | |
| Other current assets | 13.5M+171.8% | 4.97M+23.3% | 4.03M-80.0% | 20.2M+822.1% | 2.19M+23.0% | |
| 1.39B+21.5% | 1.14B+48.9% | 766M+10.6% | 692M-2.6% | 710M+35.9% | ||
| Property, plant & equipment | 383M-0.9% | 386M+33.0% | 290M+163.2% | 110M+126.6% | 48.7M+57.6% | |
| Operating lease right-of-use | 43.9M-3.0% | 45.3M-0.1% | 45.3M-22.3% | 58.3M+236.0% | 17.3M+7.5% | |
| Intangible assets | 6.86M-19.9% | 8.56M-16.6% | 10.3M-14.2% | 12.0M-12.4% | 13.7M-11.1% | |
| Other non-current assets | 1.39M-69.0% | 4.48M+37.5% | 3.26M+1395.0% | 218K-19.9% | 272K+3.0% | |
| 195M+89.5% | 103M-2.2% | 105M-24.1% | 139M-5.2% | 147M+260.2% | ||
| Accounts payable | 17.7M+55.2% | 11.4M-68.2% | 35.9M+1150.6% | 2.87M-69.7% | 9.46M+38.5% | |
| Accrued liabilities | 90.4M+43.5% | 63.0M+58.5% | 39.8M-15.1% | 46.9M+234.7% | 14.0M+159.8% | |
| Deferred revenue | 2.40M | 0.00-100.0% | 866K-98.8% | 74.1M-33.3% | 111M+475.7% | |
| Current lease liability | 7.29M+14.9% | 6.34M-40.0% | 10.6M+280.5% | 2.78M+23.4% | 2.25M+105.5% | |
| Other current liabilities | 10.8M+2402.5% | 432K-0.7% | 435K | 0.00 | — | |
| Deferred revenue (non-current) | 0.00 | — | 0.00-100.0% | 56.0M-57.5% | 131M | |
| Non-current lease liability | 104M-6.2% | 111M+6.1% | 105M+32.8% | 78.8M+238.3% | 23.3M+16.2% | |
| Operating lease liability (total) | 111M-5.1% | 117M+1.9% | 115M+41.2% | 81.6M+219.3% | 25.5M+20.8% | |
| Other non-current liabilities | — | — | — | 0.00 | — | |
| Total non-current liabilities | 686M-18.8% | 846M+126.7% | 373M+176.8% | 135M-12.9% | 155M+672.3% | |
| 466M+151.3% | 185M-31.7% | 271M-31.9% | 399M-2.5% | 409M-11.5% | ||
| Common stock | 231K+6.5% | 217K+8.5% | 200K+1.0% | 198K+0.5% | 197K+1.0% | |
| Additional paid-in capital | 2.14B+18.5% | 1.81B+38.9% | 1.30B+6.7% | 1.22B+15.7% | 1.05B+9.1% | |
| Retained earnings | -1.63B-0.1% | -1.63B-58.4% | -1.03B-25.0% | -821M-27.3% | -645M-28.0% | |
| Treasury stock | 53.2M | 0.00 | — | — | — | |
| Accumulated other comprehensive income | 6.44M+35.6% | 4.75M+247.4% | -3.22M-2269.1% | -136K-97.1% | -69.0K-483.3% | |
| Non-controlling interest | 37.4M+565.0% | 5.62M-64.5% | 15.8M-20.2% | 19.8M | 0.00 | |
| Total equity incl. non-controlling | 503M+163.5% | 191M-33.5% | 287M-31.4% | 418M+2.3% | 409M-11.5% | |
| Total liabilities & equity | 1.39B+21.5% | 1.14B+48.9% | 766M+10.6% | 692M-2.6% | 710M+35.9% | |
| Common shares issued | 138M+11.2% | 124M+15.9% | 107M+1.3% | 106M+1.6% | 104M+1.9% | |
| Common shares outstanding | 136M+9.1% | 124M+15.9% | 107M+1.3% | 106M+1.6% | 104M+1.9% | |
| Shares outstanding (cover) | 136M+9.1% | 124M+15.8% | 107M+1.3% | 106M+1.4% | 105M+1.7% | |
| Cash Flow | as ofSep 30 ’25 | as ofSep 30 ’24 | as ofSep 30 ’23 | as ofSep 30 ’22 | as ofSep 30 ’21 | |
| 180M+138.8% | -463M-200.8% | -154M-13.0% | -136M-179.5% | 171M+278.8% | ||
| Depreciation & amortization | 22.2M+31.4% | 16.9M+57.9% | 10.7M+23.0% | 8.70M+31.8% | 6.60M+57.1% | |
| Intangible amortization | 1.70M+0.0% | 1.70M+0.0% | 1.70M+0.0% | 1.70M+0.0% | 1.70M+0.0% | |
| Share-based compensation | 63.4M-14.3% | 74.0M-5.3% | 78.1M-35.4% | 121M+57.7% | 76.7M+76.7% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in receivables | 57.0M | 0.00+100.0% | -1.41M+84.1% | -8.85M-194.0% | 9.41M+5013.6% | |
| Change in payables | 6.29M+213.5% | -5.54M-116.8% | 33.0M+600.8% | -6.59M-350.7% | 2.63M+420.1% | |
| -129M+69.2% | -420M-336.9% | -96.2M-1675.1% | -5.42M+96.2% | -142M+41.2% | ||
| Capital expenditure | 22.7M-84.0% | 141M-20.0% | 177M+234.9% | 52.8M+123.9% | 23.6M+97.2% | |
| Free cash flow | 157M+126.0% | -604M-82.8% | -331M-75.0% | -189M-227.9% | 148M+237.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | 796M+10.4% | 721M+192.9% | 246M+10.2% | 223M-7.2% | 241M-13.7% | |
| Sales/maturities of investments | 690M+55.9% | 442M+35.4% | 327M+20.7% | 271M+120.9% | 123M+144.5% | |
| 74.0M-91.5% | 871M+244.0% | 253M+288.2% | 65.2M+476.6% | 11.3M-95.6% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 241M-43.8% | 429M | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | -401K-109.6% | 4.20M+3540.2% | -122K-82.1% | -67.0K+23.9% | -88.0K-121.5% | |
| Net change in cash | — | — | — | — | 40.9M+152.2% | |
| Interest paid | 19.0K | 0.00 | 0.00 | 0.00 | 0.00 | |
| Income taxes paid | 814K+121.7% | -3.74M | 0.00+100.0% | -2.00K+0.0% | -2.00K-101.9% | |
| Valuation Ratios | as ofSep 30 ’25 | as ofSep 30 ’24 | as ofSep 30 ’23 | as ofSep 30 ’22 | as ofSep 30 ’21 | |
| Market cap | 4.68B+94.3% | 2.41B-16.3% | 2.88B-17.8% | 3.50B-46.3% | 6.53B+47.5% | |
| P/S | 5.6×-99.2% | 678.8×+5937.9% | 11.2×-22.0% | 14.4×-69.5% | 47.2×-6.2% | |
| P/B | 10.1×-22.7% | 13.0×+64.6% | 7.9×-10.2% | 8.8×-44.9% | 16.0×+66.6% | |
| P/FCF | 29.9× | — | — | — | 44.2× | |
| FCF yield | 3.3% | — | — | — | 2.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ARWR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ARWR filings on SEC EDGAR → Not investment advice.